Victory Capital Management Inc Marker Therapeutics, Inc. Transaction History

Victory Capital Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$0.37 - $1.0 $230,017 - $621,670	-621,670 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$0.95 - $1.72 $270,845 - $490,372	-285,100 Reduced 31.44%	621,670 $591,000
Q3 2021 Nov 02, 2021	SELL	$1.68 - $2.88 $28,413 - $48,709	-16,913 Reduced 1.83%	906,770 $1.53 Million
Q2 2021 Aug 03, 2021	SELL	$1.88 - $3.56 $118,032 - $223,507	-62,783 Reduced 6.36%	923,683 $2.58 Million
Q1 2021 May 04, 2021	BUY	$1.47 - $3.29 $1.45 Million - $3.25 Million	986,466 New	986,466 $2.21 Million
Q2 2020 Aug 07, 2020	SELL	$1.69 - $2.79 $8,968 - $14,806	-5,307 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$1.59 - $3.35 $319 - $673	-201 Reduced 3.65%	5,307 $10,000
Q4 2019 Feb 04, 2020	SELL	$2.68 - $4.85 $163 - $295	-61 Reduced 1.1%	5,508 $14,000
Q3 2019 Nov 12, 2019	BUY	$4.1 - $9.0 $22,832 - $50,121	5,569 New	5,569 $28,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $164M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.